BerGenBio ASA (OSTO:BGBIOO) Total Liabilities : kr46.86 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Total Liabilities?

BerGenBio ASA's Total Liabilities for the quarter that ended in Dec. 2023 was kr46.86 Mil.

BerGenBio ASA's quarterly Total Liabilities declined from Jun. 2023 (kr52.41 Mil) to Sep. 2023 (kr26.84 Mil) but then increased from Sep. 2023 (kr26.84 Mil) to Dec. 2023 (kr46.86 Mil).

BerGenBio ASA's annual Total Liabilities increased from Dec. 2021 (kr65.81 Mil) to Dec. 2022 (kr78.21 Mil) but then declined from Dec. 2022 (kr78.21 Mil) to Dec. 2023 (kr46.86 Mil).

BerGenBio ASA Total Liabilities Historical Data

The historical data trend for BerGenBio ASA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Total Liabilities Chart

BerGenBio ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

50.62

67.97

65.81

78.21

46.86

BerGenBio ASA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															78.21	67.28	52.41	26.84	46.86

BerGenBio ASA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BerGenBio ASA's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	46.859	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	46.86

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	174.335	-	127.476
	=	46.86

BerGenBio ASA's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	46.859	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	46.86

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	174.335	-	127.476
	=	46.86

BerGenBio ASA Total Liabilities Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA (OSTO:BGBIOO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSTO:BGBIOO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BRRGF:USA BGBIO:Norway 7BG:Germany

Address

Mollendalsbakken 9, Bergen, NOR, 5009

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .

BerGenBio ASA (OSTO:BGBIOO) Headlines

No Headlines